Study details
Enrolling now
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Barbara Ann Karmanos Cancer Institute
NCT IDNCT00935090ClinicalTrials.gov data as of Apr 2026
Study length
about 19 years
Ages
18–120
Locations
1 site in MI
What this study is about
This trial is testing a new imaging technique called FLT PET to help find and diagnose cancer. It may also help doctors understand how well treatment will work for each patient.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use 3'-deoxy-3'-[18F]fluorothymidine
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Standard assignment
Assignment is predetermined by the study protocol.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: FLT PET response rate
Body systems
Oncology, Neurology